Angiogenesis pp 225-232 | Cite as

The Role of Thrombin and Its Receptors in Angiogenesis. Physiological and Pathological Applications

  • Michael E. Maragoudakis
  • Nikos E. Tsopanoglou
  • Eva Pipili-Synetos
Part of the NATO ASI Series book series (NSSA, volume 298)


The original observation by Trousseau (1872), that there is association between thrombosis and cancer growth and metastasis, has been verified subsequently by many investigators. Measuring circulating fibrinopeptides Rickles and Edwards (1983) have shown inappropriately high intravascular coagulation and fibrinolysis in patients with cancer. Others have shown that tumor cells interact with platelets, leukocytes and endothelial cells as well as with thrombin — and plasmin — generating systems, all of which influence clot formation (Sloan et al. 1986). In addition some tumors express the transmembrane protein tissue factor, which when exposed to factor VII activates factor X leading to generation of thrombin and fibrin formation (Tapparelli et al., 1993).


Endothelial Cell Angiogenic Action Thrombin Receptor Basement Membrane Component Matrigel Plug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Carney, D.H., Mann, R., Redin, S.D., Pernia, S.D., Berry I, Heggers J.P., Hayward, P.G., Robson, M.C., Christie J., Annable C., Fenton J.W., Genn, K.C. Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides. J. Clinical Investig. 1990; 89, 1599–1606.Google Scholar
  2. 2.
    Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1995; 1, 27–31.PubMedCrossRefGoogle Scholar
  3. 3.
    Garcia, J.G.N. Molecular mechanisms of thrombin-induced human and bovine endothelial cell activation. J. Lab. Clin. Med. 1992; 120, 513–519.PubMedGoogle Scholar
  4. 4.
    Garcia, J.G.N., Aschner, J., and Malik, A.B. Regulation of thrombin-induced endothelial cell prostaglandin synthesis and barrier function. In: Berliner, L.J., ed. Thrombin: Structure and Function. New York: Plenum Publishing, 1991; 397–430.Google Scholar
  5. 5.
    Grand, R.J.A., Turnell, A.S., and Grabham, P.W. Cellular consequences of thrombin-receptor activation. Biochem. J., 1996; 313, 353–368.PubMedGoogle Scholar
  6. 6.
    Grant, D.S., Tashiro, K.I., Segui-Real, B., Yamada, Y., Martin, G.R., and Kleinman, H.K. Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vivo. Cell 1989; 58, 933–943.PubMedCrossRefGoogle Scholar
  7. 7.
    Haralabopoulos, G.C., Grant, D.S., Kleinman, H.K., Lelkes, P.I., Papaioannou, S.P., and Maragoudakis, M.E. Inhibitors of basement membrane collagen biosynthesis prevent endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo. Lab. Invest. 1994; 71(4), 575–581.PubMedGoogle Scholar
  8. 8.
    Haralabopoulos, G., Grant, D.S., Kleinman, H.K., and Maragoudakis, M.E. Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo. Am.J.Physiol., 1997; 273 (Cell Physiol. 42), C239–C245.Google Scholar
  9. 9.
    Harris-Hooker, S.A., Gajdusek, C.M., Wight, T.N., and Schwartz, S.M. Neovascular response induced by cultured aortic endothelial cells. J. Cell Physiol. 1983; 114, 302–310.PubMedCrossRefGoogle Scholar
  10. 10.
    Kanthou, C., and Benzakour, O. Cellular effects of thrombin and their signalling pathways. Cell. Pharmacol., 1995; 2, 293–302.Google Scholar
  11. 11.
    Maragoudakis, M.E., Tsopanoglou, N.E., Sakkoula, E., and Pipili-Synetos, E. On the mechanism of promotion of angiogenesis by thrombin. FASEB J., 1995; 9, A587.Google Scholar
  12. 12.
    Nierodzik, M.L., Kajumo, F., and Karpatikiu, S. Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Cancer Res., 1992; 52, 3267–3272.PubMedGoogle Scholar
  13. 13.
    Papadimitriou, E., Manolopoulos, V., Hayman, G.T., Maragoudakis, M.E., Unsworth, B., Fenton, J.W. II, and Lelkes, P.I. Thrombin modulates vectorial secretion of extracellular matrix proteins in cultured endothelial cells. Am. Physiol. Soc. 1997; 272 (Cell Physiol. 41) C1112–C1122.Google Scholar
  14. 14.
    Passaniti, A., Taylor, R.M., Pili, R., Guo, Y., Lowrey, P.V., Haney, J.A., Daniel, R.R., Grawd, D.S., and Martin G.R. A simple quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane heparin, fibroblast growth factor. Lab Invest. 1992; 67, 519–528.PubMedGoogle Scholar
  15. 15.
    Rabiet, M.J., Plantier, J.L., Rival, Y., Genoux, Y., Lampugnani, M.G., and Dejana, E. Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. Arterioscler. Thromb. Vasc. Biol., 1996; 16, 488–496.PubMedCrossRefGoogle Scholar
  16. 16.
    Rickles, F.R., and Edwards, R.L. Activation of blood coagulation in carcer: Trousseau’s syndrome revisited. Blood, 1983:64, 14–31.Google Scholar
  17. 17.
    Sloan, B.f., Rozhin, J., Johnson K., Taylor, H., Crissman, J.D., and Honn, K.V. Cathepsin B: Association with plasma membrane in metastatic tumors. Proc. Natl. Acad. Sci. (USA) 1986, 83, 2483–2487.CrossRefGoogle Scholar
  18. 18.
    Tapparelli, C., Metternich, R., Ehrhardt, C., and Cook, N.S. Synthetic low molecular weight thrombin inhibitors: molecular design and pharmacological profile. TIPS, 1993, 14, 366–376.PubMedGoogle Scholar
  19. 19.
    Tapparelli, C., Metternich, R., and Cook, N.S. Structure and function of thrombin receptors. TIPS, 1993, 14, 426–428.PubMedGoogle Scholar
  20. 20.
    Trousseau, A. Phlegmasia alba delens in Trouseau A. Lectures in clinical medicine, delivered in Hotel-Dieu, 1872; Paris, London, New Sudenham Society 281–295.Google Scholar
  21. 21.
    Tsopanoglou, N.E., and Maragoudakis, M.E. On the mechanism of thrombin-induced angiogenesis: Inhibition of attachment of endothelial cells on basement membrane components. Angiogenesis J., 1997 (in press)Google Scholar
  22. 22.
    Tsopanoglou, N.E., Pipili-Synetos, E., and Maragoudakis, M.E. Thrombin promotes angiogenesis by a mechanism independent of fibrin formatiom. Am. J. Physiol., 1993; 264, C1302–C1307.Google Scholar
  23. 23.
    Zacharsky, L-R., Memoli, V.A., Morain, W.D., Schlaeppi, J.M. & Rousseau, S.M. Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding. Thrombosis & Haemostasis, 1995; 73, 793–797.Google Scholar
  24. 24.
    Zucker, S., Conner, C., DiMassmo, B.I., et al. Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiological regulation of angiogenesis. J. Biol. Chem. 1996; 270, 23730–23738.Google Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Michael E. Maragoudakis
    • 1
  • Nikos E. Tsopanoglou
    • 1
  • Eva Pipili-Synetos
    • 1
  1. 1.Department of Pharmacology, Medical SchoolUniversity of PatrasRio, PatrasGreece

Personalised recommendations